As mentioned, the plasma levels of urotensin II are markedly increased in several clinical conditions, including chronic kidney disease, haemodialysis6, and diabetes mellitus7, where plasma renin and aldosterone can be inappropriately high for the volume status of the patients. Here, UTS2 is linked to chronic kidney disease.